Game Over: FDA Warns Aventis For Repeat Use Of Taxotere Chess-Theme Ads
Executive Summary
Aventis' chess-themed direct-to-consumer ads for the breast and lung cancer therapy Taxotere "misleadingly...imply that survival depends on treatment with Taxotere," FDA told the company in a warning letter
You may also be interested in...
Rep. Waxman Challenges FDA Contact With Rx Companies On DTC Guides
Rep. Henry Waxman (D-Calif.) is asking FDA to defend its communications with pharmaceutical companies relating to the development of direct-to-consumer advertising guidances
Rep. Waxman Challenges FDA Contact With Rx Companies On DTC Guides
Rep. Henry Waxman (D-Calif.) is asking FDA to defend its communications with pharmaceutical companies relating to the development of direct-to-consumer advertising guidances
Aventis Plans To Launch Genasense, Ketek and Apidra In 2004
The launch of Genasense will be a key step in Aventis' plans to build its oncology franchise, Chief Operating Officer Richard Markham said Jan. 13 during the J.P. Morgan health care conference in San Francisco